More PRNewswire
View Older Stories View Newer Stories-
Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
-
Gap between Black and white renting families who could afford a mortgage narrowed significantly during the pandemic
-
Alaska Airlines adds nonstop service between Portland and Atlanta this fall
-
Reid T. Campbell Elected to the White Mountains Board
-
White Mountains Declares Annual Dividend
-
Keebeck Wealth Management Partners with iCapital® to Expand Investment Opportunities for Entrepreneurs and Families
-
Nominations Open for DrFirst's 2024 Healthiverse Heroes Award
-
Wesco Enters Agreement to Sell Integrated Supply Business to Vallen Distribution, Inc.
-
Ace Global Business Acquisition Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
-
Farmer Mac Reports 2023 Results
-
SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine
-
Capital Group Issues Capital Market Assumptions
-
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease
-
IVMF's Bunker Labs Celebrates Black History Month with new Breaking Barriers in Entrepreneurship Program Cohort
-
Difference Media Presents "Faith, Family & Friends" by Pastor Matt Hagee: A Reverent Masterpiece Featuring Acclaimed Artists
-
Ribbon Named to Newsweek's Greatest Workplaces for Women 2024
-
Lakeshore Learning Store Opens in Memphis
-
United Announces Daily Nonstop Flights Between Guam and Tokyo-Haneda
-
Ameren Missouri customers benefit from investments in stronger, smarter grid
-
Mark-Taylor Companies Debuts Season 2 of Multifamily Forward Podcast
-
New Season of I am BIO Podcast to Showcase Life-Changing Biotech Breakthroughs
-
Criteo Comments on Letter from Petrus Advisers
-
AEVOLVE Labs: aelf's New Incubator Spearheading Web3 Innovation
-
MIAMI INVESTOR SUMMIT KICKS OFF TODAY WITH GLOBAL LEADERS DISCUSSING HUMANITY'S BIGGEST CHALLENGES
-
SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
-
Actinium Highlights Improved Survival with Iomab-B in TP53 Positive Relapsed Refractory Acute Myeloid Leukemia Patients in the SIERRA Trial and Other Presentations at the 2024 Tandem Meetings | Transp
-
Scripps reports Q4 2023 financial results
-
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
-
Calumet Specialty Products Partners, L.P. Reports Fourth Quarter and Full Year 2023 Results
-
RB Global reports fourth quarter and full year 2023 results
-
JPAR® - Real Estate Celebrates Industry Recognition for Howard Ashkinos, Alejandro Franco, and Jennifer Buchanan
-
Temporary Wall Systems Las Vegas to announce grand opening at the NAHB International Builders' Show
-
TransAlta Reports Full Year and Fourth Quarter 2023 Results and Announces Enhanced Share Repurchase Program
-
Bybit Celebrates 2 Years of Peer-to-Peer Trading with Special Giveaway
-
Summit Midstream Partners, LP Schedules Fourth Quarter 2023 Earnings Call
-
Djinn Technologies Ltd. Acquires Volumetric Video Tech Pioneer, EF EVE
-
Poets&Quants™ Announces Groundbreaking Business School Showcase at Global Sustainable Development Congress
-
WARNER BROS. DISCOVERY REPORTS FOURTH-QUARTER AND FULL-YEAR 2023 RESULTS
-
Mandalay Resources Announces Normal Course Issuer Bid
-
AerCap Holdings N.V. Reports Record $3.1 Billion 2023 Net Income and Announces New $500 Million Share Repurchase Authorization
-
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
-
Securitas issues a MEUR 500 Eurobond
-
Brookdale to Present at Citi's 2024 Global Property CEO Conference and Barclays Global Healthcare Conference in March 2024
-
Summit Hotel Properties Announces 2024 Annual Meeting of Stockholders
-
CGI announces intent to repurchase 1.67 million of its shares
-
LyondellBasell Announces Quarterly Dividend
-
Disaster Relief Non-profit All Hands and Hearts Launches Program in Western Ukraine for Internally Displaced People (IDPs)
-
/C O R R E C T I O N -- TEOCO/
-
Weekly Recap: 11 Press Releases You Might Have Missed
-
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS
